The May issue of Scrip Regulatory Affairs features Voisin Consulting Life Sciences recent experience gained with the Voluntary Harmonization Procedure, which Delphine Decker recently presented at the DIA EuroMeeting (Copenhagen, March 2012). This initiative, aimed at resolving the disparities that exist among the various EU Member States, both in terms of protocol design and timelines for the review of the clinical trial application, appears to speed up the regulatory setup of multinational trials in the European Union.
Contact vcparis for more details.
